A detailed history of Atria Wealth Solutions, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 46,498 shares of AMGN stock, worth $14.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
46,498
Previous 46,084 0.9%
Holding current value
$14.5 Million
Previous $13.3 Million 0.4%
% of portfolio
0.15%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $111,312 - $134,367
414 Added 0.9%
46,498 $13.2 Million
Q4 2023

Feb 02, 2024

SELL
$255.7 - $288.46 $125,037 - $141,056
-489 Reduced 1.05%
46,084 $13.3 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $49,196 - $61,078
-225 Reduced 0.48%
46,573 $12.5 Million
Q2 2023

Aug 03, 2023

BUY
$214.27 - $253.37 $163,702 - $193,574
764 Added 1.66%
46,798 $10.4 Million
Q1 2023

Aug 22, 2023

SELL
$225.79 - $275.2 $93,251 - $113,657
-413 Reduced 0.88%
46,385 $11.2 Million
Q1 2023

Jun 14, 2023

SELL
$225.79 - $275.2 $79,252 - $96,595
-351 Reduced 0.76%
46,034 $11.1 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $31,384 - $38,252
139 Added 0.3%
46,385 $11.2 Million
Q4 2022

Aug 30, 2023

SELL
$229.03 - $291.01 $174,978 - $222,331
-764 Reduced 1.63%
46,034 $12.1 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $204,752 - $260,162
-894 Reduced 1.9%
46,246 $12.1 Million
Q3 2022

Feb 13, 2023

SELL
$224.46 - $253.15 $389,887 - $439,721
-1,737 Reduced 3.55%
47,140 $10.6 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $2.74 Million - $3.09 Million
12,223 Added 33.35%
48,877 $11.1 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $21,917 - $24,390
95 Added 0.26%
36,654 $5.74 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $8.02 Million - $8.87 Million
36,559 New
36,559 $8.84 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.